Michiko Kubo‐Kaneda
Papers
1
Total Citations
10
H-Index
1
About
Michiko Kubo‐Kaneda is a leading researcher at the intersection of gynecologic oncology and metabolic health, whose work has redefined how obesity-related risk factors are assessed in endometrial cancer care. Her most influential study, "Visceral Adipose Tissue Percentage Compared to Body Mass Index as Better Indicator of Surgical Outcomes in Women With Obesity and Endometrial Cancer" (2024, 10 citations), demonstrates a critical shift from traditional BMI metrics to more precise body composition analysis. By showing that visceral fat percentage—not just overall weight—more accurately predicts surgical complications and outcomes, Kubo‐Kaneda has provided clinicians with a powerful tool for preoperative risk stratification. This contribution is especially vital given the rising global rates of obesity and endometrial cancer. Her research not only challenges long-standing clinical assumptions but also opens new avenues for personalized treatment planning. With her work already gaining traction in the field, Kubo‐Kaneda is emerging as a key voice in the push toward precision medicine in gynecologic oncology, where metabolic profiling can improve both surgical safety and long-term patient prognosis.
Research Focus
Key Achievements
Top Papers
- 1